Will Mushrooms Get UN Approval Before Marijuana?

1/21/22, 6:40 AM Psilocybin Mushrooms May Be Rescheduled in UN Drug Treaties Before Marijuana? Wait, What?
https://cannabis.net/blog/news/psilocybin-mushrooms-may-be-rescheduled-in-un-drug-treaties-before-marijuana-wait-what 2/15
 Article List (https://cannabis.net/mycannabis/c-blog)

MUSHROOMS AND MARIJUANA AT THE UN
Psilocybin Mushrooms May Be
Rescheduled in UN Drug Treaties Before
Marijuana? Wait, What?
Mushrooms may leap frog marijuana as a de-scheduled drug at the UN
Posted by:

Chiara C, today at 12:00am
Could a worldwide policy change be the best way to kickstart research into the medicinal potential of psilocybin?

A new movement for international psychedelic reform has been put in motion. A global coalition consisting of the
Beckley Foundation, the Multidisciplinary Association For Psychedelic Studies (MAPS), Drug Science and Open
Foundation, and the Mind Medicine Australia agency launched this Push last Tuesday.
Psychedelics have been banned domestically within the U. S. and internationally for several decades. This new decade
seems to be ushering in hopes for psychedelics decriminalization and medicinal use. The global coalition hopes to
modify the international policies prohibiting the magic drug. Getting psilocybin mushrooms
(https://cannabis.net/blog/news/the-psilocybin-news-report-if-you-are-seeing-psilocybin-in-the-headlines-everywhere-
you-are-rig) internationally rescheduled may encourage U.S lawmakers to follow suit.
Tired of the Foot-Dragging
Advocates have spoken out countless times about having a bill which permits the use of psychedelics to treat certain
illnesses. However, the U.S lawmakers have done a lot of Foot-draggings instead. Just last year, a bill was finally
approved to allow a limited level of research into the drug's therapeutic potential.

The International Therapeutic Psilocybin Rescheduling Initiative (ITPRI) has begun its push for psychedelic reform. The
body is committed to rescheduling these substances banned following the United Nations 1971 convention on
psychotropics. This 1971 policy places Psilocybin as the most harmful drug on the list, hence the tight restriction on the
Psychedelic drug. In the U.S, Psilocybin also fits into the Schedule 1 category. Many advocates of Psychedelics and
cannabis believe this classification ought to be reserved for "hard" drugs that pose serious health risks to people,
regardless of their region—Drugs with little or no known medicinal benefit.
Recent developments have proven that psilocybin or magic mushrooms do not fit into the criteria for Schedule I
substances. The global organization pointed out that psilocybin is wrongly subjected to harsh limits despite its medical
potentials. An important point made during the convention is that Psilocybin could be licensed, securely manufactured
in limited quantities (for a start), and imported or exported based on acceptable regulations. This is better than the
gross oversight of the industry by international bodies.

A Push For More Research
If this push is successful, schedule I researchers can study psilocybin, magic mushroom, LSD, and other related
psychedelics. To do this, these scientists will also have to face international regulations. These hurdles won't come
cheap, adding an extra cost and complexity to the research. The prohibition of the substance by governments
worldwide may negatively impact ethical approvals, collaborations, and funding.
The first step in adequately launching this new measure will involve connecting with member nations who are a part of
the treaty signees to begin a formal review of its stance against psilocybin and other psychedelic substances. This
review will bring to light the benefits and risks of the drug. To get the process started, one country is needed to request
a review from the World Health Organization (WHO).
The WHO itself could also initiate the procedure. Once the request is made and approved, the international body's. The
Executive Committee on Drug Dependence (ECDD) would set the review process in motion. Recommendations on policy
change will be proffered by member nations. Any review that gains the support of two-thirds of signatory countries
would be signed into law, whether or not it involves a recommendation for rescheduling
Christopher Koddermann, ITPRI chair of the board of directors and co-founder, stated in a press release that a change
of psilocybin's status as a schedule I drug is way overdue. He added that there's a better scientific understanding of the
substance's high therapeutic potential and low addiction possibilities. "This is sufficient to turn the tables around," he
explained.
Possible Member Nations To Initiate Proceedings
The ITPRI says it has identified about a dozen countries willing to propose a review to reschedule psilocybin around the
world. According to Mr. Koddermann, Canada is the most suitable option from the available choices. Canada is one of a
few countries that have fully decriminalized and legalized cannabis (a schedule I substance). The country has also
loosened its restrictions on entheogen use for critically ill patients.

The founder of ITPRI partner Drug Science and head of Imperial College London's Center for Psychedelic Research,
David Butt, emphasized the coalition's shared view that the existing international scheduling of psilocybin is seriously
restricting the progress of developing treatments for neurology patients with the drug.
Willem Scholten, A former secretary to the WHO ECDD and an advisory board member with ITPRI, added that reviewing
the 1971 convention policies is a game-changing chance to push the Psilocybin industry forward. This will accelerate the
creation of life-changing medications for patients, as well as research other medical potentials the drug has.
The Coalition's Fears
As much as one member country can initiate this review process, another can oppose it. Recently the WHO maintained
its stance against prescribing Krotom (a plant well known for its pain-relieving potentials). This decision was reached
despite the results from a scientific review of the plant. The ITPRI has concerns that WHO'S ECDD could do the same if a
Rescheduling recommendation is made for Psilocybin. On Kratom, the WHO could have proposed a more critical review
that may have resulted in a reschedule, or it could have convinced member countries to regulate the drug.
In 2020, the United Nations Commission on Narcotic Drugs authorized a WHO recommendation to reschedule cannabis
from the most restrictive international scheduling category.
Psychedelics In The US
While the international coalition works tirelessly to advance the policy review initiative, pro-psychedelics groups in the
United States are also working tirelessly to initiate reforms to existing federal policies regarding plants such as
Psilocybin or magic mushrooms.
Concurrently, bills are being pushed to the Senate and House to end cannabis prohibition. Cannabis and Psychedelics
reforms are gradually gaining the Biden administration's attention.
Rep. Earl Blumenauer has sought the DEA's cooperation in allowing patient's use psilocybin legally without fearing
federal repercussions. He added that the drug would be used as an investigational treatment in ongoing clinical trials.
Lastly

Millions of people around the world are excited about the recent advancements in psychedelics research. Many of these
incredible feats will be followed by international and domestic policy changes.
UN DRUG TREATIES, READ MORE..
(https://cannabis.net/blog/news/un-drug-treaties-be-damned-germany-
imports-jamaican-cannabis-for-its-medical-marijuana-market)
UN DRUG TREATIES BE DAMNED, GERMANY IMPORTS JAMAICIAN WEED! (https://cannabis.net/blog/news/un-drug-
treaties-be-damned-germany-imports-jamaican-cannabis-for-its-medical-marijuana-market)
What did you think?
0 0 0 0 0 0

Keep reading... click here
(https://cannabis.net/blog)
Leave a Comment:
Submit
What are your thoughts?

SMOKE (HTTPS://CANNABIS.NET/BLOG/SMOKE) VIDEOS (HTTPS://CANNABIS.NET/BLOG/VIDEOS)
OPINION (HTTPS://CANNABIS.NET/BLOG/OPINION) EVENTS (HTTPS://CANNABIS.NET/BLOG/EVENTS)
NEWS (HTTPS://CANNABIS.NET/BLOG/NEWS) PERSONAL STORY (HTTPS://CANNABIS.NET/BLOG/PERSONAL-STORY)
RECIPES (HTTPS://CANNABIS.NET/BLOG/RECIPES) SPORTS (HTTPS://CANNABIS.NET/BLOG/SPORTS)
HISTORY (HTTPS://CANNABIS.NET/BLOG/HISTORY) STRAINS (HTTPS://CANNABIS.NET/BLOG/STRAINS)
DABS (HTTPS://CANNABIS.NET/BLOG/DABS) VAPING (HTTPS://CANNABIS.NET/BLOG/VAPING)
INTERVIEW (HTTPS://CANNABIS.NET/BLOG/INTERVIEW) FUNNY (HTTPS://CANNABIS.NET/BLOG/FUNNY)
TECHNOLOGY (HTTPS://CANNABIS.NET/BLOG/TECHNOLOGY) HOW TO (HTTPS://CANNABIS.NET/BLOG/HOW-TO)
SEXY (HTTPS://CANNABIS.NET/BLOG/SEXY) MEDICAL (HTTPS://CANNABIS.NET/BLOG/MEDICAL)
B2B (HTTPS://CANNABIS.NET/BLOG/B2B) LOCATIONS (HTTPS://CANNABIS.NET/BLOG/LOCATIONS)
VOTE (HTTPS://CANNABIS.NET/BLOG/VOTE)
CATEGORIES
FEATURED

(https://cannabis.net/blog/opinion/understanding-cannabis-price-fluctuations-in-state-by-state-markets)
OPINION
Understanding Cannabis Price Fluctuations in State by State Markets
What’s the price per pound of cannabis in the United States? When is it the cheapest to stock up? All of these questions are finally starting to see answers. While
Colorado isn’t the largest cannabis market within the United States, it does serve as a good indicator on the national health of the industry.

(https://cannabis.net/blog/medical/how-does-cannabis-improve-your-memory)
MEDICAL
How Does Cannabis Improve Your Memory?
The scientists conducted more research which revealed that THC showed to restore hippocampal gene transcription patterns, which is the same process that is
responsible for learning and memory in the brain.

Will Mushrooms Get UN Approval Before Marijuana?

Recommended

Recommended

More Related Content

Similar to Will Mushrooms Get UN Approval Before Marijuana?

Similar to Will Mushrooms Get UN Approval Before Marijuana? (20)

More from Evergreen Buzz

More from Evergreen Buzz (20)

Recently uploaded

Recently uploaded (20)

Will Mushrooms Get UN Approval Before Marijuana?